Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001191072-03-000003
Filing Date
2003-11-05
Accepted
2003-11-05 15:07:59
Documents
2
Period of Report
2003-11-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5086
3 EDGAR SUPPORTING DOCUMENT poa-wilson.txt EX-24 3119
  Complete submission text file 0001191072-03-000003.txt   9983
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Issuer) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address
WILSON LINDA S (Reporting) CIK: 0001191072 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26642 | Film No.: 03979278